Bicara Therapeutics Inc. ...

NASDAQ: BCAX · Real-Time Price · USD
11.66
0.25 (2.19%)
At close: Aug 15, 2025, 3:59 PM
11.64
-0.17%
After-hours: Aug 15, 2025, 05:32 PM EDT

Bicara Therapeutics Common Stock Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
Cash & Equivalents
489.71M 230.44M 4.16M
Short-Term Investments
n/a n/a n/a
Long-Term Investments
n/a n/a n/a
Other Long-Term Assets
6.62M 2.09M 1.08M
Receivables
n/a n/a n/a
Inventory
n/a n/a n/a
Other Current Assets
12.82M 633K 826K
Total Current Assets
502.53M 231.07M 4.98M
Property-Plant & Equipment
845K 815K 636K
Goodwill & Intangibles
n/a n/a n/a
Total Long-Term Assets
7.46M 2.91M 1.72M
Total Assets
510M 233.98M 6.7M
Account Payables
3.89M 3.19M 5.14M
Deferred Revenue
n/a n/a n/a
Short-Term Debt
607K 285K n/a
Other Current Liabilities
-607K 1.46M 1.18M
Total Current Liabilities
17.99M 15.09M 23.9M
Long-Term Debt
n/a n/a n/a
Other Long-Term Liabilities
n/a 17K 85K
Total Long-Term Liabilities
131K 367.67M 81.61M
Total Liabilities
18.12M 382.75M 105.51M
Total Debt
738K 657K n/a
Common Stock
7K 2K 2K
Retained Earnings
-221.02M -153.02M -101.04M
Comprehensive Income
n/a n/a n/a
Shareholders Equity
491.88M -148.77M -98.8M
Total Investments
n/a n/a n/a